<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.
Find me on:

Recent Posts

SmartTRAK'S Final 2017 Spinal Cord Stimulation Market Financial Results

Posted by Anne Staylor on 4/9/18 12:27 PM

The US Spinal Cord Stimulation market reached new heights in Q417/FY17, driven by new products, expanding indications, and a growing demand for non-narcotic alternatives for treating chronic intractable pain. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spinal Cord Stimulation Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 Spinal Cord Stimulation Market Recap are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

SmartTRAK Attending ASIPP 2018 in Orlando

Posted by Anne Staylor on 3/13/18 7:32 PM

SmartTRAK is excited to be attending #ASIPP 2018 - the 20th Annual Meeting of the American Society of Interventional Pain Physicians on March 15-17 at  the Marriot Orlando World Center in Orlando, Florida.

The educational events at ASIPP will include practice management, controlled substance management, regenerative medicine, interventional techniques, abstract presentations, a Resident/Fellow section for emergence into practice and much more. 

Anne Staylor,  Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at the conference. Please contact us if you would like a meeting.

Read More

Topics: SmartTRAK Conferences

What’s Next for Nuvectra? An Interview with CEO Scott Drees

Posted by Anne Staylor on 3/13/18 11:01 AM

Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.

A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)

Read More

Topics: Neuromodulation

SmartTRAK Attending ISC 2018 in Los Angeles CA

Posted by Anne Staylor on 1/22/18 9:00 AM

SmartTRAK is excited to be attending #ISC 2018 - International Stroke Conference, January 24-26 at the Los Angeles Convention Center.

The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease.

Read More

Topics: Neuromodulation, SmartTRAK Conferences

SmartTRAK  Attending NANS 2018

Posted by Anne Staylor on 1/8/18 6:32 PM

 

SmartTRAK is excited to be attending NANS 2018 - the North American Neuromodulation Society's 21st Annual Meeting meeting on Jan 11-14, 2018 at Caesars Palace in Las Vegas, Nevada.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Conferences

SmartTRAK Publication Alert: Q317 Spinal Cord Stim Quarterly Market Recap

Posted by Anne Staylor on 12/30/17 3:59 PM

Fast Growing Spinal Cord Stim Market Slows in Q317 

While the overall Neuromodulation Spinal Cord Stimulation (SCS) market continues to see strong, double-digit growth YTD, sequentially the US SCS market decelerated in Q317 due to seasonality and hurricane-related supply chain disruptions, particularly affecting Medtronic.

By Anne Staylor, Managing Editor, SmartTRAK Business Intelligence

YTD, the US SCS market is trending at high growth rates, a faster growth than SmartTRAK’s original 2017 forecast, as next generation products continue to drive unprecedented growth in this highly underpenetrated market. In the US, AbbottNevro and Boston Scientific’s (BSX) Q317 YoY SCS revenues increased  respectively, while competitive pressures  accelerated Medtronic’s US SCS revenue decline, down YoY according to SmartTRAK Financial Dashboard.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

High Frequency SCS for Upper Limb and Neck Pain: An Interview with Kas Amirdelfan, MD

Posted by Anne Staylor on 12/18/17 9:20 AM

Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study

Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.) 

A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

Leonardo Kapural, MD Highlights Interim Results from SENZA-CAP

Posted by Anne Staylor on 12/14/17 4:22 PM

Leonardo Kapural, MD discusses interim results from SENZA-CAP in a SmartTRAK interview at ASRA 2017

At the recent American Society of Regional Anesthesia and Pain Medicine (ASRA)
annual meeting in Lake Buena Vista, FL, Leonardo Kapural, MD, professor of anesthesiology at Wake Forest University and principle investigator of the SENZA-RCT, presented interim three month results from SENZA-CAP, a multicenter feasibility study evaluating use of 10 kHz spinal cord stimulation (SCS) for the treatment of chronic abdominal pain (CAP). (See ASRA Poster 4491.)

In an interview at ASRA, SmartTRAK spoke to Dr. Kapural regarding key findings from this study, the addressable market for SCS in chronic abdominal pain, patient engagement as a potential variable, and what’s next for this research.

A transcript of SmartTRAK’s interview with Dr. Kapural is below. Or click on the following video to view the interview recorded live at ASRA 2017. (12:06 minutes.)

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

Is Closed-Loop Spinal Cord Stim The Next Big Thing?

Posted by Anne Staylor on 11/14/17 7:04 PM

Closed-Loop Spinal Cord Stim: The Next Big Thing?

With impressive preliminary data from Saluda Medical’s AVALON trial, and all the big players working on evoked potentials, will closed-loop spinal cord stimulation (#SCS) be the next big thing?

Read More

Topics: Orthopedics-Spine, Neuromodulation-Spinal Cord Stimulation

SmartTRAK Attending ASRA 2017 Pain Medicine Meeting

Posted by Anne Staylor on 11/13/17 10:28 PM

SmartTRAK is excited to be attending ASRA- the American Society of Regional Anesthesia and Pain Medicine  on Nov 16-18, 2017 in Lake Buena Vista, FL.

The importance of pain medicine providers has never been more apparent...

Read More

Topics: SmartTRAK Conferences

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts